Journal of Cystic Fibrosis 2010
3 papers
The 2010 edition of the *Journal of Cystic Fibrosis* focused on the prevalence and management of chronic rhinosinusitis (CRS) in individuals with cystic fibrosis. Research from this year, including work by Jochen G. Mainz, B. Wiedemann, and Lutz Naehrlich, utilized multicentre interdisciplinary studies to document the frequency of sinonasal complications and survey existing therapeutic practices. These studies provided data on how CRS affects the cystic fibrosis patient population and the various methods employed by clinicians to treat the condition.
A key area of investigation involved the clinical evaluation of sinonasal inhalation treatments. One study employed a double-blind placebo-controlled cross-over design to assess the impact of dornase alfa on rhinosinusitis symptoms. The results indicated that sinonasal inhalation of this agent could lead to a reduction in symptoms. Additional research by authors such as Assen Koitschev and Irving W. Schiller contributed to the year's emphasis on upper airway health, establishing a trend toward evaluating localized therapies for respiratory complications.